Srinivas S, Pianka K, Rockwell H, Yeluru A, Liau J, Ganesh A
Cardiovasc Intervent Radiol. 2025; .
PMID: 40064654
DOI: 10.1007/s00270-025-04001-1.
Hohenberger P, Rathmann N, Busing K, Menge F, Jakob J, Pink D
Br J Cancer. 2025; .
PMID: 40044980
DOI: 10.1038/s41416-025-02952-3.
Chaikajornwat J, Tanasoontrarat W, Phathong C, Pinjaroen N, Chaiteerakij R
Liver Res. 2025; 6(1):30-38.
PMID: 39959806
PMC: 11791811.
DOI: 10.1016/j.livres.2021.07.001.
Inchingolo R, Cortese F, Pisani A, Acquafredda F, Calbi R, Memeo R
World J Gastroenterol. 2024; 30(18):2379-2386.
PMID: 38764771
PMC: 11099395.
DOI: 10.3748/wjg.v30.i18.2379.
Lee H, Alder L, Nguyen M, Dougherty S, Qu Y, Thacker L
J Gastrointest Oncol. 2023; 14(3):1378-1391.
PMID: 37435218
PMC: 10331743.
DOI: 10.21037/jgo-22-882.
Selective internal radiotherapy in Germany: a review of indications and hospital mortality from 2012 to 2019.
Mertens A, Essing T, Minko P, Mollenhoff K, Mattes-Gyorgy K, Giesel F
J Clin Transl Res. 2023; 9(2):123-132.
PMID: 37179793
PMC: 10171316.
Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides.
Liu R, Li H, Qiu Y, Liu H, Cheng Z
Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355512
PMC: 9694760.
DOI: 10.3390/ph15111339.
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.
Puleo L, Agate L, Bargellini I, Boni G, Piaggi P, Traino C
Eur Thyroid J. 2022; 11(6).
PMID: 36126186
PMC: 9641787.
DOI: 10.1530/ETJ-22-0130.
Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy.
Hosseini Shabanan S, Nezami N, Abdelsalam M, Sheth R, Odisio B, Mahvash A
Curr Oncol. 2022; 29(6):3825-3848.
PMID: 35735415
PMC: 9222092.
DOI: 10.3390/curroncol29060306.
TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC.
Guiu B, Garin E, Allimant C, Edeline J, Salem R
Cardiovasc Intervent Radiol. 2022; 45(11):1599-1607.
PMID: 35149884
DOI: 10.1007/s00270-022-03072-8.
Extrahepatic Applications of Yttrium-90 Radioembolization.
Murali N, Mouli S, Riaz A, Lewandowski R, Salem R
Semin Intervent Radiol. 2021; 38(4):479-481.
PMID: 34629717
PMC: 8497088.
DOI: 10.1055/s-0041-1735573.
Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.
Webster L, Villalobos A, Majdalany B, Bercu Z, Gandhi R, Kokabi N
Semin Intervent Radiol. 2021; 38(4):405-411.
PMID: 34629706
PMC: 8497093.
DOI: 10.1055/s-0041-1732323.
Principles of Radioembolization.
Sivananthan G, Tabori N
Semin Intervent Radiol. 2021; 38(4):393-396.
PMID: 34629704
PMC: 8497087.
DOI: 10.1055/s-0041-1735606.
Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with Y-Microspheres: A Systematic Review.
Birgin E, Rasbach E, Seyfried S, Rathmann N, Diehl S, Schoenberg S
Cancers (Basel). 2020; 12(2).
PMID: 32012709
PMC: 7072354.
DOI: 10.3390/cancers12020294.
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.
Ludwig A, Labadie K, Seo Y, Hamlin D, Nguyen H, Mahadev V
J Oncol. 2019; 2019:4564707.
PMID: 31636665
PMC: 6766125.
DOI: 10.1155/2019/4564707.
Hepatic supraselective radioembolization, today and new horizons.
Orcajo Rincon J, Regi A, Leyte M, Martin L, Pascual R, Farto J
Eur J Nucl Med Mol Imaging. 2019; 46(12):2412-2413.
PMID: 31456019
DOI: 10.1007/s00259-019-04492-4.
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Saini A, Wallace A, Alzubaidi S, Knuttinen M, Naidu S, Sheth R
J Clin Med. 2019; 8(1).
PMID: 30621040
PMC: 6352151.
DOI: 10.3390/jcm8010055.
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Kis B, El-Haddad G, Sheth R, Parikh N, Ganguli S, Shyn P
Cancer Control. 2017; 24(3):1073274817729244.
PMID: 28975829
PMC: 5937250.
DOI: 10.1177/1073274817729244.
[Liver metastases of colorectal cancer].
Hoffmann R
Radiologe. 2017; 57(2):90-96.
PMID: 28130578
DOI: 10.1007/s00117-017-0208-0.
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
Lee E, Alanis L, Cho S, Saab S
Korean J Radiol. 2016; 17(4):472-88.
PMID: 27390539
PMC: 4936170.
DOI: 10.3348/kjr.2016.17.4.472.
